Can exocrine pancreatic insufficiency cause iron deficiency and is low stool elastase-1 a supporting diagnostic marker?

Exocrine pancreatic insufficiency (EPI) is characterized by the inadequate secretion of pancreatic enzymes and bicarbonate, leading to a cascade of digestive complications. This condition fundamentally disrupts the breakdown and absorption of nutrients, with significant implications for both macro- and micronutrient status.

Clinical evidence and nutrient deficiencies

EPI is a well-established cause of maldigestion, primarily resulting from the failure to secrete sufficient lipases, proteases, and amylases into the small intestine. This failure leads to malabsorption, with fat malabsorption (steatorrhea) being the most prominent clinical sign.

• Micronutrient Impact: Beyond fat-soluble vitamins (A, D, E, and K), research confirms that EPI contributes to mineral deficiencies, including iron. Patients with conditions such as chronic pancreatitis or specific genetic mutations (e.g., COX4I2) frequently present with iron deficiency and subsequent anemia.
• Response to Treatment: Clinical data show that iron status often improves when pancreatic enzyme replacement therapy (PERT) is combined with iron supplementation, reinforcing the link between exocrine function and nutrient uptake. Guidelines for managing chronic pancreatitis now routinely recommend screening for iron deficiency due to this known risk.

Diagnostic role of Fecal Elastase-1

Fecal elastase-1 (FE-1) is a primary, non-invasive biomarker used to support a diagnosis of EPI. Because elastase-1 is a protease that remains stable during intestinal transit and is concentrated in the stool, it serves as a reliable proxy for pancreatic secretory capacity.

• Diagnostic Accuracy: Large-scale meta-analyses demonstrate that FE-1 is highly accurate, particularly for moderate-to-severe EPI. A standard cutoff of <200 μg/g provides a pooled sensitivity of approximately 0.94 and a diagnostic odds ratio of 35.27.
• Severity Correlation: While the test is exceptionally sensitive (up to 100%) in severe cases, its sensitivity may decrease to roughly 53% in mild EPI, where direct pancreatic function tests (like secretin-stimulation) remain the gold standard.

Mechanistic explanations

The mechanism of maldigestion in EPI is multifactorial. The lack of enzymes prevents the physical breakdown of food, while a concurrent reduction in bicarbonate secretion prevents the neutralization of gastric acid.

• PH and Iron Solubilization: Adequate pancreatic bicarbonate is necessary to maintain a duodenal pH that facilitates the solubilization of inorganic iron. In EPI, an overly acidic environment in the duodenum may impair the solubility and subsequent transport of iron across the intestinal mucosa.
• Enzyme Stability: Fecal elastase-1 is highly specific to the pancreas and does not degrade significantly in the gut, making its concentration in stool a direct reflection of the acinar cell output.

Bottom line

Exocrine pancreatic insufficiency causes significant maldigestion and iron deficiency, and a low fecal elastase-1 (<200 μg/g) is a validated, highly sensitive diagnostic marker for confirming the condition.